2023 international evidence-based guideline pcos glp-1 receptor agonist Research progress on insulin resistance in polycystic ovary syndrome 2023 International Evidence-based Guideline on
Description
Findings continued at 36 weeks
Mild to moderate transient gastrointestinal side effects were the most frequently reported adverse events associated with tirzepatide treatment and were similar in frequency and intensity compared to semaglutide (nausea 17%22% vs
One major research goal is to separate appetite suppression from nausea
Mayendraraj, A., Rosenkilde, M
doi: 10.1210/en.2003-0323
